Inquiry Basket
N-(2-(3, 4-Difluorophenoxy)ethyl)-4-formylbenzamide is a linker for antibody-drug-conjugation (ADC).
| Catalog Number | Size | Price | Quantity | |
|---|---|---|---|---|
| BADC-00565 | -- | $-- | Inquiry |
N-(2-(3,4-Difluorophenoxy)ethyl)-4-Formylbenzamide, often recognized in the field of medicinal chemistry, has emerged as a vital compound with potential therapeutic applications. Its unique chemical structure enables it to interact with various biological targets, making it a significant subject of study in the development of novel pharmaceuticals. The presence of difluorophenoxy and formylbenzamide groups in its structure imparts unique electronic properties that are pivotal for its biological activity. Researchers are closely investigating its potential as a lead compound in drug discovery projects focused on treating chronic diseases, including cancer and inflammatory disorders.
A major application of N-(2-(3,4-Difluorophenoxy)ethyl)-4-Formylbenzamide is in oncology, where its role as a potential anti-cancer agent is being explored. The compound's ability to inhibit specific cancer cell proliferation pathways presents a promising therapeutic strategy. Studies have shown that it may induce apoptosis in cancerous cells, reduce tumor growth, and enhance the effectiveness of existing chemotherapy drugs. This has led to its consideration as a candidate for combination therapy, aiming to improve patient outcomes while minimizing adverse effects associated with conventional cancer treatments.
In addition to its anti-cancer properties, N-(2-(3,4-Difluorophenoxy)ethyl)-4-Formylbenzamide shows promise in treating inflammatory diseases. Its unique structure allows it to modulate the activity of certain enzymes and receptors involved in inflammation. By inhibiting these pathways, the compound could potentially reduce the symptoms of diseases such as rheumatoid arthritis and inflammatory bowel disease. Researchers are conducting in vitro and in vivo studies to further understand its efficacy and safety profile, with the goal of developing more effective anti-inflammatory medications.
Furthermore, N-(2-(3,4-Difluorophenoxy)ethyl)-4-Formylbenzamide is being studied for its potential in neurodegenerative disease research. The compound's properties suggest it might protect neuronal cells from degenerative processes, providing a new approach to treating conditions like Alzheimer's and Parkinson's disease. Ongoing research aims to elucidate the mechanisms by which this compound can offer neuroprotection, ultimately leading to innovative therapies that can halt or reverse the progression of neurodegenerative diseases. This application highlights the versatility of the compound and its relevance in addressing various unmet medical needs.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
